Interestingly, a variant of the Wnt/Dkk1 receptor LRP6, which displays reduced Wnt signaling in cell lines, is associated with an increased risk for late-onset AD (De Ferrari et al., 2007). This evidence concerns the gene LRP6 and Alzheimer disease.